capsaicin 0.000325 MG/MG / lidocaine hydrochloride 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG Topical Ointment [LidoPro]
- RxCUI
- 1601097
- RxNorm name
- capsaicin 0.000325 MG/MG / lidocaine hydrochloride 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG Topical Ointment [LidoPro]
- Display name
- LIDOPRO (Topical)
- Full name
- capsaicin 0.000325 MG/MG / lidocaine hydrochloride 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG Topical Ointment [LidoPro]
- Term type
- SBD
- Status
- Active
- Strength
- 0.0325-4-10-27.5%
- Dose form
- Ointment
- Route
- Topical
- Updated
- 2026-10-15 15:44:29
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 032015
- Active start
- 032015
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| capsaicin | 0.000325 MG / 1 MG | capsaicin | capsaicin |
| methyl salicylate | 0.275 MG / 1 MG | methyl salicylate | methyl salicylate |
| lidocaine hydrochloride | 0.04 MG / 1 MG | lidocaine | lidocaine hydrochloride |
| menthol | 0.1 MG / 1 MG | menthol | menthol |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Topical Ointment | 316985 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| capsaicin | 1992 |
| methyl salicylate | 29787 |
| lidocaine | 6387 |
| menthol | 6750 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | LidoPro (capsaicin 0.0325 % / lidocaine HCl 4 % / menthol 10 % / methyl salicylate 27.5 % ) Topical Ointment | 1 | NAMES |
| RxNorm Name | capsaicin 0.000325 MG/MG / lidocaine hydrochloride 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG Topical Ointment [LidoPro] | 1 | NAMES |
| RxNorm Synonym | LidoPro (capsaicin 0.0325 % / lidocaine HCl 4 % / menthol 10 % / methyl salicylate 27.5 % ) Topical Ointment | 1 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 2 | CODES | |
| RxCUI | 1601097 | 1 | CODES |
| MMSL_CODE | BD29989 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 68788-8314-1 | 68788-8314 | LidoPro Capsaicin, Lidocaine, Menthol, and Methyl Salicylate | Preferred Pharmaceuticals Inc. | |
| 68788-8833-9 | 68788-8833 | LidoPro Pain Relief Capsaicin and Lidocaine | Preferred Pharmaceuticals Inc. | M017 |
| 80425-0452-1 | 80425-0452 | LidoPro Pain Relief Capsaicin and Lidocaine | Advanced Rx of Tennessee, LLC | M017 |
| 83881-001-35 | 83881-001 | LidoPro Pain Relief Capsaicin and Lidocaine | Clinic Pharma | M017 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| M017 | 68788-8833 | LidoPro Pain Relief Capsaicin and Lidocaine | OTC MONOGRAPH DRUG | Preferred Pharmaceuticals Inc. |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LidoPro | CAPSAICIN, LIDOCAINE, MENTHOL, AND METHYL SALICYLATE | Preferred Pharmaceuticals Inc. | 3b5ea9b4-6a5b-4ee8-b4d8-ece9b840adfd | 2025-07-17 | Warnings | 68788-8314-1 68788-8314 68788831401 1601097 |
| LidoPro Pain Relief | CAPSAICIN AND LIDOCAINE | Preferred Pharmaceuticals Inc. | c259ef92-5d07-4590-adf1-3a106333eee0 | 2025-02-21 | Warnings | 68788-8833-9 68788-8833 68788883309 1601097 |
| LidoPro Pain Relief | CAPSAICIN AND LIDOCAINE | Advanced Rx of Tennessee, LLC | 27d5997b-1cc2-41c2-e063-6394a90ac74a | 2025-01-15 | Warnings | 80425-0452-1 80425-0452 80425045201 |
| LidoPro Pain Relief | CAPSAICIN AND LIDOCAINE | Clinic Pharma | 274611ea-7fc2-ba3f-e063-6294a90aa50f | 2024-11-19 | Warnings | 83881-001-35 83881-001 83881000135 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3b5ea9b4-6a5b-4ee8-b4d8-ece9b840adfd | LidoPro 0.0325 % / 4 % / 10 % / 27.5 % Topical Ointment [PSN] · capsaicin 0.000325 MG/MG / lidocaine hydrochloride 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG Topical Ointment [LidoPro] [SBD] · LidoPro (capsaicin 0.0325 % / lidocaine HCl 4 % / menthol 10 % / methyl salicylate 27.5 % ) Topical Ointment [SY] | 3 | 3 | LidoPro 4% Ointment | 20250717 |
| c259ef92-5d07-4590-adf1-3a106333eee0 | LidoPro 0.0325 % / 4 % / 10 % / 27.5 % Topical Ointment [PSN] · capsaicin 0.000325 MG/MG / lidocaine hydrochloride 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG Topical Ointment [LidoPro] [SBD] · LidoPro (capsaicin 0.0325 % / lidocaine HCl 4 % / menthol 10 % / methyl salicylate 27.5 % ) Topical Ointment [SY] | 3 | 1 | 83881-001 LidoPro Transdermal Pain Relief & Applicator | 20250221 |
| 7f672876-477c-4333-a7de-53f312190661 | LidoPro 0.0325 % / 4 % / 10 % / 27.5 % Topical Ointment [PSN] · capsaicin 0.000325 MG/MG / lidocaine hydrochloride 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.275 MG/MG Topical Ointment [LidoPro] [SBD] · LidoPro (capsaicin 0.0325 % / lidocaine HCl 4 % / menthol 10 % / methyl salicylate 27.5 % ) Topical Ointment [SY] | 3 | 1 | LIDOPRO OINTMENT | 20170221 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| e3a1e298-fa87-4d16-e053-2995a90acabd | TP05-LidoPro 4% Ointment | Terrain Pharmaceuticals | Westwood Laboratories, LLC | 20251103 |
| e3a1e298-fa87-4d16-e053-2995a90acabd | LidoPro 4% Ointment | Terrain Pharmaceuticals | Westwood Labratories, LLC. | 20250814 |
| 3b5ea9b4-6a5b-4ee8-b4d8-ece9b840adfd | LidoPro 4% Ointment | Preferred Pharmaceuticals Inc. | 20250717 |
| c259ef92-5d07-4590-adf1-3a106333eee0 | 83881-001 LidoPro Transdermal Pain Relief & Applicator | Preferred Pharmaceuticals Inc. | 20250221 |
| 27d5997b-1cc2-41c2-e063-6394a90ac74a | LidoPro Ointment 99gm | Advanced Rx of Tennessee, LLC | 20250115 |
| fc5f831c-169f-de28-e053-6394a90a8f1f | LidoPro Ointment | Advanced Rx Pharmacy of Tennessee, LLC | 20241231 |
| 274611ea-7fc2-ba3f-e063-6294a90aa50f | 83881-001 LidoPro Transdermal Pain Relief & Applicator | Clinic Pharma | 20241119 |
| 12daded2-c5f6-97cc-e063-6294a90aa6ee | TP05-LidoPro 4% Ointment | Medsource Pharmaceuticals | Westwood Laboratories, LLC | 20240304 |
| 7d3113a3-aa2f-496b-b7cf-182aa7420ce0 | LIDOPRO OINTMENT | Lake Erie Medical DBA Quality Care Products LLC | 20231221 |
| 81000fe7-276c-455e-b758-f5b863cb98f1 | LidoPro 4% | Terrain Pharmaceuticals | 20231208 |
| e48aa0ab-6aed-4dae-8e1c-dfae2e70f303 | LidoPro 4% | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 20231016 |
| e8ee1f03-f369-416b-a366-c1879a6c0a7b | LidoPro 4% Ointment | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 20231016 |
| f2561493-d181-3aa9-e053-2a95a90a83cb | Lidopro Ointment | Direct_Rx | 20230727 |
| f4ec0b40-88c9-42ca-97e9-bae5e2e38577 | LidoPro 4% | Preferred Pharmaceuticals | 20220901 |
| 875fb4ec-d5f2-ad7f-e053-2995a90a6c40 | LIDOPRO OINTMENT | DirectRX | 20190425 |
| 7d64b023-f33d-444b-e053-2a91aa0a5ed2 | LidoPro 4% | medsource pharmaceuticals | 20181219 |
| 84954b67-6c5e-4b45-8c8a-9cd4fc325ec7 | LidoPro 4% | A-S Medication Solutions | 20180522 |
| fc4f4081-b332-4083-aa99-e70c8e4e5005 | LIDOPRO OINTMENT | Preferred Pharmaceuticals, Inc. | 20171107 |
| 7f672876-477c-4333-a7de-53f312190661 | LIDOPRO OINTMENT | Aidarex Pharmaceuticals LLC | 20170221 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N01BB | Amides | ATC1-4 | lidocaine | |
| ATC | S02DA | Analgesics and anesthetics | ATC1-4 | lidocaine | |
| ATC | D04AB | Anesthetics for topical use | ATC1-4 | lidocaine | |
| ATC | R02AD | Anesthetics, local | ATC1-4 | lidocaine | |
| ATC | C01BB | Antiarrhythmics, class Ib | ATC1-4 | lidocaine | |
| ATC | M02AB | Capsaicin and similar agents | ATC1-4 | capsaicin | |
| ATC | S01HA | Local anesthetics | ATC1-4 | lidocaine | |
| ATC | C05AD | Local anesthetics | ATC1-4 | lidocaine | |
| ATC | N01BX | Other local anesthetics | ATC1-4 | capsaicin | |
| FDASPL | N0000175682 | Amide Local Anesthetic | EPC | has_epc | lidocaine |
| FDASPL | N0000175426 | Antiarrhythmic | EPC | has_epc | lidocaine |
| FDASPL | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine |
| MEDRT | D002211 | Capsaicin | CHEM | has_ingredient | capsaicin |
| MEDRT | D008012 | Lidocaine | CHEM | has_ingredient | lidocaine |
| MEDRT | D008012 | Lidocaine | CHEM | has_ingredient | lidocaine hydrochloride |
| MEDRT | D008610 | Menthol | CHEM | has_ingredient | menthol |
| MEDRT | D012459 | Salicylates | CHEM | has_ingredient | methyl salicylate |
| MEDRT | D059787 | Acute Pain | DISEASE | may_treat | methyl salicylate |
| MEDRT | D000219 | Adams-Stokes Syndrome | DISEASE | ci_with | lidocaine |
| MEDRT | D000219 | Adams-Stokes Syndrome | DISEASE | ci_with | lidocaine hydrochloride |
| MEDRT | D001168 | Arthritis | DISEASE | may_treat | methyl salicylate |
| MEDRT | D001416 | Back Pain | DISEASE | may_treat | methyl salicylate |
| MEDRT | D002056 | Burns | DISEASE | may_treat | lidocaine |
| MEDRT | D002056 | Burns | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D003288 | Contusions | DISEASE | may_treat | methyl salicylate |
| MEDRT | D003929 | Diabetic Neuropathies | DISEASE | may_treat | capsaicin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | lidocaine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | capsaicin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | methyl salicylate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | lidocaine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | menthol |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | lidocaine |
| MEDRT | D004935 | Esophageal Diseases | DISEASE | may_treat | lidocaine |
| MEDRT | D004935 | Esophageal Diseases | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D006562 | Herpes Zoster | DISEASE | may_treat | capsaicin |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | lidocaine |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | lidocaine hydrochloride |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | methyl salicylate |
| MEDRT | D009059 | Mouth Diseases | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D009059 | Mouth Diseases | DISEASE | may_treat | lidocaine |
| MEDRT | D009120 | Muscle Cramp | DISEASE | may_treat | methyl salicylate |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D009437 | Neuralgia | DISEASE | may_treat | capsaicin |
| MEDRT | D010146 | Pain | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | lidocaine hydrochloride |
| MEDRT | D010146 | Pain | DISEASE | may_treat | menthol |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | capsaicin |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | lidocaine |
| MEDRT | D010146 | Pain | DISEASE | may_treat | lidocaine |
| MEDRT | D012871 | Skin Diseases | DISEASE | may_treat | menthol |
| MEDRT | D013180 | Sprains and Strains | DISEASE | may_treat | methyl salicylate |
| MEDRT | D013614 | Tachycardia, Paroxysmal | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D013614 | Tachycardia, Paroxysmal | DISEASE | may_treat | lidocaine |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | may_treat | lidocaine |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D018754 | Ventricular Dysfunction | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | lidocaine |
| MEDRT | D018879 | Ventricular Premature Complexes | DISEASE | may_treat | lidocaine |
| MEDRT | D018879 | Ventricular Premature Complexes | DISEASE | may_treat | lidocaine hydrochloride |
| MEDRT | N0000000069 | Calcium Channel Antagonists | MOA | has_moa | menthol |
| MEDRT | N0000000160 | Cyclooxygenase Inhibitors | MOA | has_moa | methyl salicylate |
| MEDRT | N0000000105 | Neurotransmitter Transporter Interactions | MOA | has_moa | capsaicin |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | methyl salicylate |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | lidocaine |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | lidocaine hydrochloride |
| MEDRT | N0000008330 | Cardiac Rhythm Alteration | PE | has_pe | lidocaine |
| MEDRT | N0000008330 | Cardiac Rhythm Alteration | PE | has_pe | lidocaine hydrochloride |
| MEDRT | N0000008472 | Decreased Cardiac Muscle Organized Electrical Activity | PE | has_pe | lidocaine |
| MEDRT | N0000008472 | Decreased Cardiac Muscle Organized Electrical Activity | PE | has_pe | lidocaine hydrochloride |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | methyl salicylate |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | lidocaine hydrochloride |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | capsaicin |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | lidocaine |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | menthol |
| MEDRT | N0000009006 | Decreased Thromboxane Production | PE | has_pe | methyl salicylate |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine hydrochloride |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.000325 MG/MG / 0.04 MG/MG / 0.1 MG/MG / 0.275 MG/MG |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| NAMES | Prescribable Synonym | LidoPro 0.0325 % / 4 % / 10 % / 27.5 % Topical Ointment |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |